Vaccines
16 March 2020
BioNTech reports rapid progress on COVID-19 vaccine program to address global public health threat12 March 2020
Virometix Announces Initiation of Phase 1 Clinical Trial With Its V-306 Vaccine Candidate11 March 2020
Novavax and Serum Institute of India to Develop and Commercialize Malaria Vaccine Candidate5 March 2020
EpiVax Accelerates COVID-19 Vaccine Development with UGA’s Center for Vaccines and Immunology4 March 2020
Heat Biologics Launches Program to Develop Vaccine Designed to Protect Against COVID-19 Coronavirus29 February 2020
Generex Provides Coronavirus Update: Generex Receives Contract from Chinese Partners to Develop a COVID-19 Vaccine Using Ii-Key Peptide Vaccines29 February 2020
Altimmune Completes First Development Milestone Toward a Single-Dose Intranasal COVID-19 Vaccine29 February 2020
Biohaven’s NURTEC™ ODT (rimegepant) Receives FDA Approval for the Acute Treatment of Migraine in Adults29 February 2020
Anokion Announces Initiation of Patient Dosing in Phase 1 Clinical Trial of KAN-101 in Celiac Disease27 February 2020
Advaxis Announces Updated Positive Clinical Data in Ongoing Phase 1/2 ADXS-503 Trial in NSCLC at I/O 360° Conference26 February 2020
Novavax Advances Development of Novel COVID-19 Vaccine25 February 2020
IO Biotech Announces Positive Outcome of Interim Analysis of Phase 2 Randomized Trial in First Line Non-small Cell Lung Cancer25 February 2020
IMV Inc. Announces Breakthrough Data from DeCidE1, its Ongoing Phase 2 Study of DPX-Survivac in Patients with Advanced Recurrent Ovarian CancerNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports